O'Reilly, Eileen M <br/><br/>
Neoadjuvant or Adjuvant Therapy for Resectable or Borderline Resectable Pancreatic Cancer: Which Is Preferred?  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  06 2020 
 - 1757-1759 p.  digital 
<br/><br/> Publication Type: Editorial; Research Support, N.I.H., Extramural; Comment 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.19.03318  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Chemoradiotherapy<br/>Humans<br/>Neoadjuvant Therapy<br/>Pancreatic Neoplasms--drug therapy